Navigation Links
Sequenom, Inc. Announces Date Of Third Quarter 2013 Financial Results And Conference Call
Date:10/24/2013

SAN DIEGO, Oct. 24, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the third quarter of 2013 after closing of the NASDAQ Global Market on Thursday, November 7, 2013.

A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm EST (2:00 pm PST) and will be webcast live on the Sequenom Web site. 

To access the live teleconference call, dial 877-883-0383 in the U.S. and Canada, and 412-902-6506 for other international callers. Please use code 1655358. If you are unable to listen to the live webcast, a teleconference replay will be available through Friday, November 29, 2013. Interested parties can access the replay by dialing 877-344-7529 or 412-317-0088 internationally and entering the conference number 10035907.

The conference call webcast is accessible through the "Investors" section of the Sequenom Web site at http://www.sequenom.com/invest. An online replay will be available following the initial broadcast until Friday, November 29, 2013. 

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genomic and genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostic markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

(Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO)


'/>"/>
SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Todays Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
2. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
3. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
4. Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012
5. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
6. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
7. Berger & Montague, P.C. Announces That Omnicare, Inc. Agrees to Pay $120 Million to Settle Kickback Allegation
8. Hill-Rom Reports Fiscal Fourth Quarter and Full-Year Results; Announces Fiscal 2014 Financial Outlook
9. Only the Breast Announces Innovative Milk Banking Program and Partnership
10. Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Repros Therapeutics, Inc.
11. Kush Bottles Announces New Canadian Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25, 2016 Digital Health ... to it by the US Patent and Trademark ... technology includes proprietary processes for electronic opt-­in and ... and wellness programs, HIPAA compliance and otherwise. ... "Our technology allows for ...
(Date:5/25/2016)... 2016 ReportsnReports.com adds "Chronic ... that provides an overview on therapeutic pipeline of ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Chronic Cough ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
Breaking Medicine Technology:
(Date:5/25/2016)... Diego, CA (PRWEB) , ... May 25, 2016 , ... There was a time when ... women are going with the flow and turning to menstrual cups, like Lunette . ... party, Lunette is introducing their new anthem in this catchy video ! , ...
(Date:5/25/2016)... ... May 25, 2016 , ... New studies published ... injured workers across 15 states. The outcomes examined in these studies include recovery ... care, and satisfaction with medical care. , “The goal of the studies is ...
(Date:5/25/2016)... ... May 25, 2016 , ... The ... Drug Development through Molecular Imaging.” The focus of ADDMI-IG will be geared towards ... and development pipeline issues. Through ADDMI-IG WMIS will provide a platform for productive ...
(Date:5/25/2016)... , ... May 25, 2016 , ... ... to industries ranging from medical and pharmaceutical, to food and HVAC facilities. Their ... as on-site training. , For medical applications, Afrimesure offers a variety of ...
(Date:5/25/2016)... ... May 25, 2016 , ... The University of San Francisco (USF) has named ... lead a team of more than 100 full-time faculty and staff, and serve as ... in late August. , Baker comes to USF from the University of Washington in ...
Breaking Medicine News(10 mins):